GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medy-Tox Inc (XKRX:086900) » Definitions » Short-Term Capital Lease Obligation

Medy-Tox (XKRX:086900) Short-Term Capital Lease Obligation : ₩525 Mil (As of Dec. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Medy-Tox Short-Term Capital Lease Obligation?

Medy-Tox's Short-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₩525 Mil.

Medy-Tox's quarterly Short-Term Capital Lease Obligation declined from Jun. 2023 (₩293 Mil) to Sep. 2023 (₩0 Mil) but then increased from Sep. 2023 (₩0 Mil) to Dec. 2023 (₩525 Mil).

Medy-Tox's annual Short-Term Capital Lease Obligation declined from Dec. 2021 (₩572 Mil) to Dec. 2022 (₩411 Mil) but then increased from Dec. 2022 (₩411 Mil) to Dec. 2023 (₩525 Mil).

Medy-Tox Short-Term Capital Lease Obligation Historical Data

The historical data trend for Medy-Tox's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medy-Tox Short-Term Capital Lease Obligation Chart

Medy-Tox Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Short-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 391.44 558.87 571.91 411.35 525.21

Medy-Tox Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Short-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 411.35 - 293.48 - 525.21

Medy-Tox Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Medy-Tox Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Medy-Tox's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Medy-Tox (XKRX:086900) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medy-Tox Inc (XKRX:086900) » Definitions » Short-Term Capital Lease Obligation
Comparable Companies
XKRX:048410 XKRX:145020 XKRX:214450 XKRX:141080 XKRX:096530 XKRX:085660 XKRX:016790 XKRX:064550 XKRX:298380 XKRX:005250 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
641-4, Gak-Ri, Ochang-Eup, Cheongwon, KOR, 363885
Website
http://www.medytox.com
Medy-Tox Inc. is a Korea-based company engaged in the development, manufacture, and marketing of biopharmaceuticals. The company's main product is type-A botulium toxin biopharmaceuticals which are used as remedies for blepharospasms, hemifacial spasms, eye wrinkles, hyperhidrosis diseases and infantile cerebral palsy. The group provides its products under the brand names of Neuronox, Siax and others. It distributes its products within Korean and to overseas markets, such as Japan, China, Russia and Europe, among others.

Medy-Tox (XKRX:086900) Headlines

No Headlines